糖皮质激素在治疗气管支气管结核中的应用进展

doi:10.3969/j.issn.2095-3755.2019.04.013

摘要/Abstract

摘要：

目前,糖皮质激素(glucocorticoids,GCS)在治疗气管支气管结核(tracheobronchial tuberculosis,TBTB)中的作用仍存在争议和矛盾。一些研究发现,TBTB活动阶段的治疗目标是控制感染和预防气管支气管狭窄。早期TBTB炎症活动阶段可以通过短期使用吸入型糖皮质激素(inhaled corticosteroids,ICS)以控制炎症、减轻症状、预防支气管狭窄,但需警惕和严密监测ICS-TB相关性肺炎、非结核分枝杆菌性肺病、肺癌发生的可能。

关键词: 糖皮质激素类, 支气管疾病, 结核, 预防和防护用药, 综述

Abstract:

There are still disputes and contradictions about the role of glucocorticoids (GCS) in the treatment of tracheobronchial tuberculosis (TB). Some studies found that the treatment for the patients with active tracheobronchial TB aimed to control infection and prevent tracheobronchial stenosis. At the early stage of inflammatory in the patients with active with tracheobronchial TB, inhaled corticosteroids (ICS) can be used to control inflammation, relieve symptoms and prevent bronchostenosis. However, the possibility of occurrence of ICS-TB-related pneumonia,nontuberculous mycobacterial pulmonary disease or lung cancer need to be vigilant and closely monitored.

Key words: Glucocorticoids, Bronchial diseases, Tuberculosis, Protective agents, Review

杨伏萍,雷坤,杨松. 糖皮质激素在治疗气管支气管结核中的应用进展[J]. 结核病与肺部健康杂志, 2019, 8(4): 299-302. doi: 10.3969/j.issn.2095-3755.2019.04.013

Fu-ping YANG,Kun LEI,Song YANG. Research progress on glucocorticoids application in treatment of patients with tracheobronchial tuberculosis[J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 299-302. doi: 10.3969/j.issn.2095-3755.2019.04.013

参考文献 30

[1]	Mondoni M, Repossi A, Carlucci P , et al. Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis, 2017,64:27-37. doi: 10.1016/j.ijid.2017.08.008 URL pmid: 28864395
[2]	Şimşek A, Yapıcı I, Babalık M , et al. Bronchoscopic diagnostic procedures and microbiological examinations in proving endobronchial tuberculosis . J Bras Pneumol, 2016,42(3):191-195. doi: 10.1590/S1806-37562015000000134 URL pmid: 27383932
[3]	Sahin F, Yıldız P . Characteristics of endobronchial tuberculosis patients with negative sputum acid-fast bacillus. J Thorac Dis, 2013,5(6):764-770. doi: 10.3978/j.issn.2072-1439.2013.12.15 URL
[4]	覃红娟, 谭守勇, 邝浩斌 , 等. 727例气管支气管结核临床特点分析. 中国防痨杂志, 2017,39(3):238-241.
[5]	Guo X, Wang C, Wang X , et al. Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis. Exp Ther Med, 2014,8(3):781-784. doi: 10.3892/etm.2014.1804 URL
[6]	Jung SS, Park HS, Kim JO , et al. Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis. Respirology, 2015,20(3):488-495. doi: 10.1111/resp.12474 URL pmid: 25620110
[7]	孙瑞琳, 金发光, 谢永宏 , 等. 支气管镜在气管支气管结核诊断中的临床价值. 中华肺部疾病杂志(电子版), 2016,9(1):10-12.
[8]	邝浩斌, 谭守勇, 梁敏青 , 等. 耐多药肺结核患者并发气管支气管结核的相关性研究. 中国防痨杂志, 2017,9(3):242-246.
[9]	黎燕琼, 谭守勇 . 重视气管支气管结核的危害性. 中国防痨杂志, 2017,39(3):220-221.
[10]	Cary C, Jhajj M, Cinicola J , et al. A rare case of fibrostenotic endobronchial tuberculosis of trachea. Ann Med Surg (Lond), 2015,4(4):479-482. doi: 10.1016/j.amsu.2015.10.007 URL pmid: 26779339
[11]	Kashyap S, Solanki A . Challenges in endobronchial tuberculosis: from diagnosis to management. Pulm Med, 2014,2014:594806. doi: 10.1155/2014/594806 URL pmid: 25197570
[12]	中华医学会结核病学分会. 气管支气管结核诊断和治疗指南(试行). 中华结核和呼吸杂志, 2012,35(8):581-587.
[13]	Pathak V, Shepherd RW, Shojaee S . Tracheobronchial tuberculosis. J Thorac Dis, 2016,8(12):3818-3825. doi: 10.21037/jtd.2016.12.75 URL pmid: 28149582
[14]	Lee P . Endobronchial tuberculosis. Indian J Tuberc, 2015,62(1):7-12. doi: 10.1016/j.ijtb.2015.02.002 URL pmid: 25857560
[15]	Nemir RL, Cardona J, Vaziri F , et al. Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. Ⅱ. Further term observation. Am Rev Respir Dis, 1967,95(3):402-410. doi: 10.1164/arrd.1967.95.3.402 URL pmid: 5335164
[16]	Toppet M, Malfroot A, Derde MP , et al. Corticosteroids in primary tuberculosis with bronchial obstruction. Arch Dis Child, 1990,65(11):1222-1226. doi: 10.1136/adc.65.11.1222 URL pmid: 2248533
[17]	Rikimaru T, Kinosita M, Yano H , et al. Diagnostic features and therapeutic outcome of erosive and ulcerous endobronchial tuberculosis. Int J Tuberc Lung Dis, 1998,2(7):558-562. URL pmid: 9661822
[18]	Shaikh WA . Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy, 1992,47(4 Pt 1):327-330. doi: 10.1111/j.1398-9995.1992.tb02063.x URL pmid: 1443454
[19]	杨松, 严晓峰 . 气管支气管结核的诊治进展. 结核病与肺部健康杂志, 2017,6(3):282-285.
[20]	Singh A, Nandan D, Dewan V , et al. Comparison of clinical effects of beclomethasone dipropionate & budesonide in treatment of children with mild persistent asthma: A double-blind, randomized, controlled study. Indian J Med Res, 2016,144(2):250-257. doi: 10.4103/0971-5916.195040 URL pmid: 27934805
[21]	苗雅 . 布地奈德吸入辅助治疗支气管结核的临床疗效观察. 中国防痨杂志, 2013,35(2):151-152.
[22]	Pandya D, Puttanna A, Balagopal V . Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J, 2014,8:59-65. doi: 10.2174/1874306401408010059 URL pmid: 25674175
[23]	Postma DS, Roche N, Colice G , et al. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD. Int J Chron Obstruct Pulmon Dis, 2014,9:1163-1186. doi: 10.2147/COPD.S68289 URL pmid: 25378918
[24]	Hossny E, Rosario N, Lee BW , et al. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J, 2016,9:26. doi: 10.1186/s40413-016-0117-0 URL pmid: 27551328
[25]	Barnes PJ . Glucocorticosteroids: current and future directions. Br J Pharmacol, 2011,163(1):29-43. doi: 10.1111/j.1476-5381.2010.01199.x URL pmid: 21198556
[26]	Hashemian SM, Mortaz E, Jamaati H , et al. Budesonide facili-tates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells. J Crit Care, 2018,44:161-167. doi: 10.1016/j.jcrc.2017.10.045 URL pmid: 29127842
[27]	Lee CM, Heo J, Han SS , et al. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study. J Allergy Clin Immunol Pract, 2019,7(4):1197-1206. doi: 10.1016/j.jaip.2018.10.007 URL pmid: 30339858
[28]	Brode SK, Campitelli MA, Kwong JC , et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J, 2017, 50(3). pii: 1700037. doi: 10.1183/13993003.00037-2017 URL pmid: 28931659
[29]	Ni S, Fu Z, Zhao J , et al. Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis. J Thorac Dis, 2014,6(7):971-978. doi: 10.3978/j.issn.2072-1439.2014.07.03 URL
[30]	Wu MF, Jian ZH, Huang JY , et al. Post-inhaled corticos-teroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD. BMC Cancer, 2016,16(1):778. doi: 10.1186/s12885-016-2838-4 URL pmid: 27724847